Indications
Malaria prophylaxis, consistent with the approved use of ARAKODA
Warnings and precautions
Hemolytic Anemia G6PD Deficiency in Pregnancy and Lactation Methemoglobinemia Psychiatric Effects Hypersensitivity Reactions Delayed Adverse Reactions, Including Hemolytic Anemia, Methemoglobinemia, Psychiatric Effects, and Hypersensitivity Reactions
Official product information
This product has no Drugs@FDA application number in our table. DailyMed holds the labels the manufacturers submit.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Kodatef
- Active substance
- tafenoquine
- Application
- LABEL-Kodatef
- NDC
- 71475-258-03